Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjögren's syndrome, mixedcryoglobulinemia and idiopathic systemic vasculitis

Clinical and Experimental Rheumatology

Volumn 25, Issue 4, 2007, Pages 556-562

  Alpa, M ^a   Ferrero, B ^b   Cavallo, R ^a,b   Perna, A ^c   Naretto, C ^a   Gennaro, M ^a   Di Simone, D ^a   Bellizia, L ^a   Mansouri, M ^a   Rossi, D ^a   Modena, V ^a,b   Giachino, O ^a   Sena, L M ^a   Roccatello, Dario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

ANCA associated vasculitis; Anti neuronal antibodies; Mixed cryoglobulinemia; Sj gren's syndrome; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; STEROID; SULFATIDE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; ENZYME ASSAY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROPATHY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; CRYOGLOBULINEMIA; FEMALE; GANGLIOSIDOSIS, GM1; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; SULFOGLYCOSPHINGOLIPIDS; VASCULITIS;

EID: 34648825175     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. NOBILE ORAZIO E, CARPO M, LEGNAME G, MEUCCI N, SONNINO S, SCARLATFO G: Anti-GM1 IgM antibodies in motor neuron disease and neuropathies. Neurology 1990; 40: 1747-50.
2. PESTRONK A: Motor neuropathies, motor neuron disordors and anti-glycolipid antibodies. Muscle Nerve1991; 14: 927-36.
3. SADIQ SA, THOMAS FP, KILIDIREAS K et al.: The spectrum of neurologic diseases associated with anti-GM1 antibodies. Neurology 1990; 40: 1067-72.
4. PESTRONK A, LI F, GRIFFIN J, FELDMAN EL et al.: Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991; 41: 357-62.
5. DABBY R, WEIMER LH, HAYS HP, OLARTE M, LATOV N: Anti-sulfatide antibodies in neuropathy. Clinical and electrophysiologic correlate. Neurology 2000; 54: 1448-52.
6. ARASAKI K, KUSONIKI S, KUDO N, KANASAWA I: Acute conduction block in vitro following exposure to anti-ganglioside sera. Muscle Nerve 1993; 16: 587-93.
7. TAKIGAWA T, YASUDA H, KIKKAWA R, SHIGETA Y, SAIDA T, KITASATO H: Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelifiated nerve fibers. Ann Neurol 1995; 37: 436-42.
8. WEBER F, RÜDEL R, AULKEMEYER P, BRINKMEIER H: Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve 2000; 23: 1414-20.
9. MC COMBE PA, WILSON R, PRENTICE LR: Results of testing for anti-GM1 antibodies. J Clin Neurosci 2000; 7: 209-12.
10. CARPO M, ALLARIA S, SCARLATO G, NOBILE ORAZIO E: Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy. Neurology 1999; 53: 2206.
11. ESTES D, CHRISTIAN CL: The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971; 50: 85-95.
12. DUBOIS EL, TUFFANELLI DL: Clinical manifestations of systemic lupus erythematosus: Computer analysis of 520 cases. JAMA 1964; 190: 104-11.
13. HUYNH C, HO SL, FONG KY, CHEUNG RTF, MOK CC, LAU CS: Peripheral neuropathy in systemic lupus erythematosus. J Clin Neurophysiol 1999; 16: 164-68.
14. ROALD O, SVEIN IM, LASSE G et al.: Small nerve fiber involvement in systemic lupus erythematosus. Arthriis Rheum 2002; 46: 1228-32.
15. VAN LAARHOVEN H W, ROOYER F A, VAN ENGELEN BG, VAN DALEN R, BERDEN JH: Guillain-Barré syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment. Nephrol Dial Transplant 2001; 16: 840-42.
16. GEORGESCU L, MEVORACH D, ARNETT FC, REVEILLE JD, ELKON KB: Anti-P antibodies and neuropsychiatric lupus erythematosus. Ann N YAcad Sci 1997; 823: 263-69.
17. HASHIMOTO H: Peripheral neuropathies in lupus patients with anti-GM1 antibodies. Intern Med 1999; 38: 689-90.
18. GALEAZZI M, ANNUNZIATA P, SEBASTIANI GD et al.: Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE. J Rheumatol 2000; 27: 135-41.
19. DEGIORGIO LA, KONSTANTINOV KN, LEE SC, HARDIN JA, VOLPE BT, DIAMOND BA: Subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189-93.
20. ZEBALLOS RS, FOX RI, CHERESH DA, MCPHERSON RA: Anti-glycosphingolipid autoantibodies in rheumatologic disorders. J Clin Lab Anal 1994; 8: 378-84.
21. BANSAL AS, ABDUL-KARIM B, MALIK RA et al.: IgM ganglioside GMI antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol 1994 Apr; 47: 300-02.
22. GIORDANO N, LUCANI B, AMENDOLA A et al.: IgG and IgM antiganglioside M1 antibodies in primary Sjögren's syndrome with and without peripheral neuropathy. Clin Rheumatol 2003; 22: 256-58.
23. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-77.
24. ROCCATELLO, D, MORSICA G, PICCIOTTO G et al.: Impaired bepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinemia and hepatitis C virus (HCV) infection. Clin Exp Immunol 1997; 110: 9-14.
25. VITALI C, BOMBARDIERI S, JONSSON R et al.: European Study Group on Classification Criteria for Sjögren's syndrome: Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-58.
26. JENNETTE JC, FALK RJ, ANDRASSAY K et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
27. ALEADINI A, WIRGUIN I, LATOV N: Ganglioside agglutination imummoassay for rapid detection of autoantibodies in immune-mediated neuropathy. J Clin Lab Anal 2001; 15: 96-9.
28. THOMAS PK, OCHOA J: Clinical features and differential diagnosis. In: DYCK PJ, THOMAS PK, GRIFFIN JW, LOW PA, PODUSLO JF, eds. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders, 1993: 749-74.
29. ISOARDO G, FERRERO B, BARBERO P et al.: Anti-GM1 and anti-sulfatide antibodies in polyneuropathies. Threshold titers and accuracy. Acta Neurol Scand 2001; 103: 180-87.
30. AD Hoc SUBCOMMITTEEOF AMERICAN ACADEMY OF NEUROLOGY AIDS TASK FORCE : Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIPD). Neurology 1991; 41: 617-18.
31. COLLINS MP, KISSEL JT, MENDELL JR: Vasculitic neuropathies. In: ANTEL J, BIRNBAUM G, HARTUNG HP, eds. Clinical Neuroimmunology. Malden: Blackwell Science 1998; 316-39.
32. LHOTE F, GUILLEVIN L: Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Clinical aspects and treatment. Rheum Dis Clin North Am 1995; 21: 911-47.
33. DAVIES L, SPIES JM, POLLARD JD et al.: Vasculitis confined to peripheral nerves. Brain 1996; 119: 1441-48.
34. PAGNOUX C, GUILLEVIN L: Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol 2005; 17: 41-8.
35. YUKI N, TAKI T, INAGAKI F et al.: A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993; 178: 1771-75.
36. PRENDERGAST MM, LASTOVICA AJ, MORAN AP: Lipopolysaccharides from Campylobacter Jejuni O:41 strains associated with Guillain-Barré syndrome exhibit municry of GM1 ganglioside. Infect Immun 1998; 66: 3649-55.
37. MORI M, KUWABARA S, MIYAKE M et al.: Haemophilus influenzae has a GMI ganglioside-like structure and elicits Guillain-Barré syndrome. Neurology 1999; 52: 1282-84.